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Pain is an unpleasant sensory and emotional 
experience associated with actual or potential tissue 
damage mainly due to tissue trauma. 
Post-operative pain is not avoidable in surgery. The 
treatment   of    post-operative   pain   results   in   real 
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benefits to the patients and surgical units. Although 
pain has a purpose in the wider evolutionary sense, it 
is a largely inappropriate maladaptive response in the 
post-operative period, which is associated with stress 
and systemic complications that include pulmonary, 
cardiovascular and gastrointestinal ones. Uncontrolled 
pain may cause struggling, crying, and restlessness 
and may result in hematoma formation and thereby 
delay wound healing. Adequate pain control leads to 
decreased manipulation of the surgical site and thus 
reduces swelling, hematoma formation, and 
infection.[1] 
Some of the analgesics are tested to pacify surgical 
pain namely anesthetics and analgesic. Whereas 
others, to pacify post-operative pain and its 
complications. All these drugs are categorized under 
opioids, NSAIDs and other synthetic and semi 
synthetic groups. Most of them produce a potent 
analgesic action but none of them are devoid of their 
A B S T R A C T  
Introduction: Post-operative pain is physiological pain which is caused due to tissue trauma. Drugs 
such as NSAIDs (Non Steroidal Anti Inflammatory Drugs) and Opioids are used for post-operative pain 
management but are associated with their own drawbacks. Shirish has been in use in Ayurvedic 
practice for analgesia. It is known to relieve pain and can be used to supplement anesthesia and also 
get rid of adverse effect of modern analgesic drugs. Aims and Objective: To study the comparative 
effect of Shirish and Diclofenac sodium in post-operative pain management. Materials and Methods: 
Randomized clinical trial with Group A (Control Group: Tab Diclofenac sodium 50 mg as a single dose) 
and Group B (Trial Group: Cap Shirish 500 mg as a single dose). Those who had undergone surgeries 
like hernia, appendicitis operation under spinal anesthesia were selected as per inclusion criteria. 
Vitals, desirable effect and undesirable effect, total surgical time, the assessment criteria observed 
and recorded. Results: Cap. Shirish does not show any undesirable or serious ill effects and altered 
values of vitals as per statistical analysis. As per visual assessment scale, pain felt by Trial group was 
earlier than control group. Conclusions: Shirish Vati has analgesic property but its analgesic property 
and pain threshold capacity is lesser than those of Diclofenac Sodium. 
Key words: Anesthesia, Hernia, Appendicitis, Shirish, Pain, Inguinoscrotal Surgeries. 
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known systemic and hence are used with certain 
limitations. 
In the texts of Ayurveda, a large number of drugs are 
mentioned under the heading Vedanasthāpana 
(~analgesic), Śothahara (anti-inflammatory), 
Vātaśāmaka (controlling of Vāta) and Śūlapraśamana 
(pain reliever) groups and at different places with 
their specific analgesic actions. According to 
Ayurveda, vitiation of Vāta is the prime factor 
producing pain perception along with other systemic 
consequences such as palpitation, depression, 
insomnia, vomiting, irritation, hypertension, 
excitement etc.[2] 
Analgesia is a component of anesthesia. Ayurveda 
drugs which relieve pain could be used to supplement 
anesthesia as well as get rid of adverse effects of 
modern drugs. Some Ayurvedic physicians use herbal 
preparations for analgesia. One such preparation is 
Shirish Vati. According to Ayurvedic literature, Shirish 
is Tridoṣahara and indicated in Śiras (head), Mukha 
(mouth) and Danta (dental) Tvak (skin) diseases. 
Chemically Shirish contain tanin and saponin. 
Therefore, on the basis of Ayurveda references 
indicating Vātahara properties of these drugs and 
reverse pharmacology of these drugs, this study has 
been taken up to provide clinical evidence of analgesic 
property of Shirish Vati comparing it with Diclofenac 
sodium. In the present study, Shirish Vati[3]is prepared 
in the form of a capsule contains powder of seeds. 
MATERIALS AND METHODS 
60 patients who were to undergo inguinoscrotal 
operation under spinal anesthesia were randomly 
selected using a random number table. They were of 
either sex with in Shalya Tantra ward. They were 
divided into two groups using sequentially numbered 
opaque envelopes i.e., group A and group B each 
consisting of 30 patients of either sex. Group A 
(Control) was given Diclofenac sodium and group B 
(Trial) was given Shirish Vati in the form of capsule. 
Both control drug and trial drug were given 
preoperatively one day before operation and 60-90 
min preoperatively and postoperatively after 
appearance of pain at 8hr. intervals for three days. 
SOS medicine was also given per group. Assessment 
was done using subjective and objective parameters. 
Collection and preparation of drug 
Ingredient of Shirish is leaf, flower, seed, root. Shirish 
were collected from their respective natural habitats 
and were authenticated. Seed of Shirish was dried, 
powdered. The resultant powder was filled in 500 mg 
capsules and preserved in an air tight container. Thus, 
Shirish capsule (Churna) was prepared with the 
standard preparatory methods as mentioned in the 
texts of Ayurveda. 
Grouping of patients 
After obtaining Institutional Ethical committee 
approval, the trial was registered the Clinical Trial 
Registry of India, CTRI. All 60 patients were randomly 
divided in two equal and identical groups consisting of 
30 patients by using sequential numbering using 
opaque envelopes. 
Groups Group A Group B 
Drug Diclofenac sodium Shirish Vati 
Sample size 30 30 
Drop out No No 
Dose(mg) 50 500 
Route Orally Orally 
Group A (Control Group) 
Patients were given tablet Diclofenac sodium 50 mg 
as single dose orally with an ounce of plain water pre 
and post operatively in inguinoscrotal operation 
under spinal anesthesia as per the following schedule: 
One tablet the night before operation with 10 - 20 ml 
of water; one tab 60 to 90 min before operation with 
10-20 ml of water. Post-operative follow up was as 
follows: Day 1: 50 mg Diclofenac sodium given when 
patient complains of pain and the drug is repeated at 
8-hour intervals; Day 2 and 3: 50 mg Diclofenac 
sodium given at 8-hour intervals. 
Group B (Trial Group) 
Patients were given 3 capsules of 500 mg each Shirish 
Vati as a single dose orally with an ounce of plain 
water pre and post operatively in inguinoscrotal 
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operation under spinal anesthesia as per the following 
schedule: three capsules of 500 mg each with 10 – 20 
ml of water the night before operation, three capsules 
of 500 mg each with 10-20 ml of water 60-90 min 
before operation. Post-operative follow up was as 
follows Day 1: three capsules of 500 mg as one dose 
given when patient complains of pain and the drug is 
repeated at 8-hour intervals, Day 2 and day 3: 500 mg 
three capsules one dose given at 8-hour intervals. 
Preoperative preparation and premeditation 
All the patients were assessed thoroughly and consent 
was taken about the proposed research work. Their 
age (years), weight (kg) and vital signs viz. pulse rate, 
blood pressure, respiratory rate, oxygen-saturation 
and axillary temperature were recorded. General 
condition, physiological and psychological conditions 
were also recorded. After complete satisfaction, the 
grouping was done as discussed earlier. 
Post operatively time for first analgesic and pain 
before administration of first analgesic was recorded 
as per case proforma. Three days follow up was done 
according to case proforma. During this follow up, 
capsules Shirish and tablets Diclofenac sodium were 
given to respective groups as per drug dosage 
schedule. Pain assessment was done using Visual 
Analog Scale before every dose of control and study 
group medication. Effects such as sedation, 
apprehension, excitement, dizziness, nausea etc., 
were observed and recorded as per case proforma. 
RESULTS 
All the data collected viz. age, blood pressure, pulse 
rate, respiratory rate, total surgical time, difference of 
visual analogue scale (VAS) 1 of first post-operative 
day with VAS 1 of third post-operative day and VAS 3 
of first post-operative day with VAS 3 of third post-
operative day between groups etc., were also 
recorded. Mean, standard deviation (SD), applying 
unpaired t-test, t-value, standard error, P value, using 
percentage of incidence and degree of freedom etc., 
were calculated. Requirement of Rescue Analgesic in 
both Groups are depicted. 
 
Required of rescue analgesic in both groups 
DISCUSSION 
In Ayurveda, analgesia is achieved by drugs 
mentioned in Sāṅgyasthāpana Gaṇa, 
Vedanāsthāpana Gaṇa, Vātahara Dravya, 
Vātānulomana and Śūlapraśamana Dravya. Mode of 
actions of these drugs are mainly based on Rasa, 
Vīrya, Vipāka and Prabhāva. Vaidyas use different 
herbal drugs in combinations for the purpose of 
analgesia. In the present study, Shirish was selected 
which is used for analgesia by Vaidyas. Capsule 
containing Shirish seed Churṇa which used to evaluate 
post-operative pain relief in inguinoscrotal operation 
under spinal anesthesia.[4] 
Diclofenac Sodium, one of the widely used NSAIDs 
agent, is an insoluble compound in acidic solution, but 
dissolves in intestinal fluid and water. In order to 
eliminate the gastrointestinal adverse effects of this 
drug, several swellable controlled-release 
pharmaceutical dosage forms have been developed. 
In Control group, altered mean blood pressure intra-
operatively returned to basal sooner than study 
group. Therefore, it can be said that both drugs 
decrease pain and stress response preoperatively with 
the control drug being more effective. On the basis of 
these findings, it can be concluded that the study drug 
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Shirish has no serious ill effects on cardio vascular 
system and it does not alter Blood Pressure. 
Mean pulse rate during the course of the observations 
before premedication and after recovery from 
anesthesia within the group is significant in group B 
and insignificant in group A. In Group A, there is no 
change of pulse rate at the time of observation before 
premedication and post operatively. Hence the 
altered mean pulse rate during operation is treated to 
be basal for post-operative readings. In Group B 
postoperative mean pulse rate decreased compared 
to preoperative but still it was more than the basal 
pulse rate. Hence, in the Control group altered mean 
heart rate intra-operatively reverts to basal sooner 
than the study group. 
Mean respiratory rate/min within both groups before 
premedication versus after premedication, before 
premedication versus intra-operative and before 
premedication versus after recovery from anesthesia 
were identical. The observations prove that there is 
no effect of either the study or control drugs on the 
respiratory rate. 
The response of analgesic premedication plays a 
definite role during post-operative period with regard 
to duration of surgery. Observations recorded suggest 
that total surgical duration was identical in both 
groups and statistically insignificant when compared 
between the groups. The sustained release ability of 
Diclofenac sodium was demonstrated in an in-vivo 
study, showing the presence of the drug in plasma for 
about 14 h. 
Mean VAS Scale (subjective) between the groups at 
corresponding times i.e. First (VAS 1), second (VAS 2) 
and third (VAS 3) reading at every 8hrs. of third post-
operative day were observed. The results seem to 
suggest VAS 1 to be statistically insignificant and VAS 
2, VAS 3 to be significant between the group A 
(Control) and Group B (study).  
Pain has decreased from VAS 1 up to VAS 3 in both 
groups. But the reduction in the control group is more 
than that in the study group. Difference in VAS 1 and 
VAS 3 between both groups statistically insignificant 
and equal. Difference of VAS 1 of first post-operative 
day with VAS 1 of third post-operative day and VAS 3 
of first post-operative day with VAS3 of third post-
operative day between groups is equal and 
statistically insignificant. All the above proves the 
analgesic property of Shirish Vati compared to 
Diclofenac sodium. As VAS scale decreased on all 
three days between control group and study group 
equally, a statistically insignificant result is obtained. 
Except last day where VAS Scale decrease in control 
group is earlier than in the study group. This goes to 
prove the analgesic property of Shirish Vati and it 
being lesser than that of Diclofenac sodium. 
Statistical comparison of difference in mean VAS Scale 
(Objective) between the groups at corresponding time 
i.e., first (VAS 1), second (VAS 2) and third (VAS 3) 
reading at every 8hrs. interval of first post-operative 
day was observed. VAS 1, VAS 2 is equal and 
insignificant in both groups but VAS3 is significant 
statistically. VAS 3 is more in Study group and that 
means that the patients experience discomfort. In 
control group, VAS 3 is zero and hence the patients 
experience no discomfort are completely at ease.  
This shows that Control drug is associated with lesser 
pain than the study drug. No major difference is 
observed between the groups was observed on 
second and third day respectively and it is zero for all 
results in both groups. Both group patients were 
having no discomfort and patient completely at ease 
on second and third day. The above proves the 
analgesic property of both drugs. Difference of VAS1 
of first post-operative day with VAS1 of third post-
operative day which is statistically insignificant and 
difference of VAS 3 of first post-operative day with 
VAS 3 of third post-operative day between groups, 
both of which are statistically significant results, are 
obtained. 
Rescue analgesic required was 27% in Study group 
which almost 3 times than in control group. This also 
shows that the study group patients felt more pain 
than control group in spite of the drug. This proves 
that Shirish Vati has less analgesic property than study 
group and it alone is not sufficient to control post-
operative pain. 
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CONCLUSION 
Shirish Vati has analgesic property but it's analgesic 
property and pain threshold capacity is lesser than 
control drug. Shirish cap does not show any toxic 
effect in animals and neither does it show undesirable 
effects in humans. It is used solitarily, hence is not 
sufficient to control post-operative pain. 
Characterization of compounds responsible for 
analgesic property in Shirish Vati needs to be studied 
further to enhance the potency of Shirish Vati to make 
it a novel analgesic. 
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